News
Numerous companies are producing automated pharmacy systems that upgrade pharmaceutical workplaces every day. Learning which ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to acoramidis (Beyonttra) for adult ...
MAGIC-I, which is Ireland’s first clinical study of genomics approaches in cancer care, will seek to establish the processes ...
As part of the deal Astex has acquired a 19% equity stake in Mosaic upfront with a potential for an additional 3% upon reaching clinical milestones. Dr Harren Jhoti Co-founder President and Chief ...
Researchers from University College London (UCL) are aiming to develop potential treatments for congenital muscular dystrophy ...
Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah ...
Terumo Blood and Cell Technologies (Terumo BCT) has announced the appointment of Patrick Daly as its Chief Business Officer.
Clinical-stage biopharma Kymera Therapeutics has announced the appointment Noah Goodman as its new Chief Business Officer.
New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer ...
The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...
The European Commission has granted marketing authorisation for Leqembi (lecanemab), making it the first therapy in the EU to slow the progression of early Alzheimer’s disease.
Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results